International Biotechnology Trust’s Genmab GMAB Stock Holding History

International Biotechnology Trust’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.56M	Buy	+44,300	New	+$1.69M	0.53%	43
2023 Q2	–	Sell	-88,000	Closed	-$3.32M	–	70
2023 Q1	$3.32M	Buy	+88,000	New	+$3.38M	0.93%	32
2022 Q3	–	Sell	-1,857	Closed	-$57.2K	–	74
2022 Q2	$57.2K	Buy	+1,857	New	+$60.2K	0.6%	38

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

International Biotechnology Trust's GMAB Position: Q3 2023 in Review

International Biotechnology Trust opened a new position in Genmab (GMAB) in Q3 2023: 44,300 shares worth $1.56M. The stake represents 0.53% of the portfolio and ranks #43 among its holdings. This is a return to the name: International Biotechnology Trust previously reported a position in GMAB as recently as Q1 2023.

International Biotechnology Trust first reported a position in GMAB in Q2 2022 and has held it in 3 quarters since. The position peaked at $3.32M in Q1 2023. 234 funds tracked by Wall St. Rank hold GMAB as of Q3 2023.

International Biotechnology Trust held 44,300 shares of Genmab worth $1.56M as of Q3 2023.
Genmab was a new International Biotechnology Trust position in Q3 2023.
Genmab made up 0.53% of International Biotechnology Trust's portfolio in Q3 2023, its #43 holding.
International Biotechnology Trust first reported a position in Genmab in Q2 2022 and has held it in 3 quarters since.
International Biotechnology Trust's Genmab position peaked at $3.32M in Q1 2023.
234 funds tracked by Wall St. Rank held Genmab as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.